A Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy With Synovial Biopsy Substudy.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Toreforant (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 10 Jun 2017 Biomarkers information updated
- 04 Jun 2013 Status changed from active, no longer recruiting to discontinued.
- 24 Mar 2012 Planned number of patients changed from 90 to 95 as reported by European Clinical Trials Database.